DrInes Cebola

I am a Sir Henry Dale Fellow and Senior Lecturer in Regulatory Genomics in the Department of Metabolism, Digestion and Reproduction at Imperial College London (UK), where I lead the lab of Regulatory Genomics and Metabolic Disease.

I have a long-standing interest and expertise in the application of wet and dry lab approaches to regulatory genomics in the context of human disease. This expertise is demonstrated by seminal work I led during my postdoctoral training under the mentorship of Prof Jorge Ferrer, with whom I investigated the contribution of sequence variation at transcriptional enhancers to different forms of human diabetes.

In 2019, I transitioned to an independent group leader position, focusing on the investigation of genetic and epigenomic mechanisms leading to metabolic disease through liver dysfunction. This transition into a distinct research field has been supported by a strongly hepatology-minded environment at Imperial College London, where I have close collaborations with clinical endocrinologists and hepatologists, as well as liver basic researchers. Ever since my appointment as lecturer, my lab’s liver research has been supported by leading national and international funding schemes, including the award of a Sir Henry Dale Fellowship by the Wellcome Trust (start date: 01/04/2022).

In addition to my main role as research group leader, I am an honorary clinical scientist affiliated with England’s National Health Service (NHS), where I coordinate a collaboration with the North West Thames Regional Genetics service, joining clinical geneticists and Imperial College academics to study causal variants in individuals with monogenic disorders lacking genetic diagnosis.